ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
23 announcements with these filters
Kovai Medical extended the completion deadline for the slump sale of its AHS division to a related-party trust to January 31, 2027. Cash consideration is Rs.84.54 Lakhs.
Kovai Medical Center and Hospital Ltd reported revenue from operations of ₹472.6 Cr (+20.8% YoY) and net profit of ₹77 Cr (+30.7% YoY) for Q2 FY27.
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
Kovai Medical Center intimated BSE that its Board will meet on 11 Nov 2026 to approve unaudited results for the quarter ended 30 Sep 2026. No financial figures or other decisions are disclosed yet.
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a routine periodic regulatory disclosure with no new transaction.
Promoter Pavai Property Developers acquired 316 shares of Kovai Medical Center via open market purchase for ₹0.19 Crore. This increases their holding slightly.
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
Kovai Medical Center shareholders approved Dr. Arun N Palaniswami's re-designation as Joint Managing Director via postal ballot. The resolution passed with 96% assent in September 2026.
Kovai Medical Center and Hospital Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-designation of Dr. Arun N Palaniswami as Joint Managing Director.
Promoter Palaniswami N acquired 12,59,725 shares (11.51% stake) of Kovai Medical Center via inheritance. His total holding increased from 0.09% to 11.60% post-transaction.
Kovai Medical Center and Hospital Limited has reconstituted its Corporate Social Responsibility Committee, effective from August 7, 2026. This is a routine governance update.
Kovai Medical Center and Hospital Ltd has re-designated Dr. Arun N Palaniswami as the Joint Managing Director of the company, effective August 07, 2026.
Kovai Medical Center and Hospital Ltd reported revenue from operations of ₹430.9 Cr (+15.3% YoY) and net profit of ₹69.1 Cr (+20.8% YoY) for Q1 FY27.
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, noting the transmission of shares due to a promoter's demise.
Kovai Medical Center and Hospital Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March, 2026.
Kovai Medical Center and Hospital Limited has issued a notice for its Annual General Meeting on August 26, 2026. The agenda includes financial statements and dividend declaration.
Kovai Medical Center & Hospital Ltd will hold a Board Meeting on 07/08/2026. The meeting will consider the un-audited financial results for the quarter ended 30th June 2026.
Kovai Medical Center and Hospital announced the sad demise of Joint Managing Director Dr. Thavamani Devi Palaniswami. She served on the board since July 2000.
Kovai Medical Center corrected an arithmetical error in its Q4 tax expense, revising the figure to ₹20.92 Crore. The company confirmed annual figures remain unchanged.
Kovai Medical Center & Hospital revised its Q4 FY26 financial results to correct an arithmetical error in tax expense. Total tax was adjusted to ₹20.92 Crore.
Kovai Medical Center and Hospital Limited scheduled its 40th AGM for August 26, 2026. The Board recommended a final dividend of Rs. 15 per share.
Kovai Medical Center and Hospital Ltd reported revenue from operations of ₹413.2 Cr (+15.9% YoY) and net profit of ₹59.7 Cr (+9.1% YoY) for Q4 FY26.
Kovai Medical Center reported audited annual results for FY26 and recommended a 150% final dividend. The board also fixed the August 2026 record date.